Table 1.
Laboratory characteristics at the administration
| Value | Normal range | |
|---|---|---|
| Urinalysis | ||
| Protein | (3 +) | (−) |
| Occult blood | (−) | (−) |
| Granular cast | (−) | (−) |
| β-2 microglobulin (μg/L) | 9923 | 16–518 |
| N-acetyl-β-D-glucosaminidase (IU/L) | 30.7 | 1–4.2 |
| Blood count | ||
| White blood cell (/μL) | 4500 | 3300–8800 |
| Red blood cell (/μL) | 312 × 104 | 430–550 × 104 |
| Hemoglobin (g/dL) | 7.7 | 13.5–17.0 |
| Hematocrit (%) | 23.8 | 39.7–51.0 |
| Platelet (/μL) | 12.9 × 104 | 13.0–35.0 × 104 |
| Erythrocyte fragmentation | (−) | (−) |
| Serum chemistry | ||
| BUN (mg/dL) | 26.1 | 8.0–20.0 |
| Cr (mg/dL) | 2.31 | 0.60–1.00 |
| eGFR (mL/min/1.73m2) | 21 | > 60 |
| UA (mg/dL) | 5.4 | 3.6–7.0 |
| Na (mEq/L) | 139 | 135–149 |
| K (mEq/L) | 3.1 | 3.5–4.9 |
| Cl (mEq/L) | 101 | 96–108 |
| Total bilirubin (mg/dL) | 0.7 | 0.4–1.5 |
| ALP (IU/L) | 199 | 115–359 |
| AST (IU/L) | 19 | 13–33 |
| ALT (IU/L) | 13 | 8–42 |
| LDH (IU/L) | 276 | 119–229 |
| Total protein (g/dL) | 6.9 | 6.7–8.3 |
| Albumin (g/dL) | 3.9 | 4.0–5.0 |
| Haptoglobin (mg/dL) | < 10 | 19–170 |
| Coagulation system | ||
| PT (%) | 73 | 70–130 |
| APTT (second) | 91.7 | 22.0–43.0 |
| Fibrinogen (mg/dL) | 415 | 160–450 |
| d-dimer (mg/dL) | 0.8 | 0.0–1.0 |
| Immunological findings | ||
| CRP (mg/dL) | 0.18 | 0.0–0.3 |
| CH50 (U/mL) | 30.4 | 25.0–48.0 |
| C3 (mg/dL) | 93 | 65–135 |
| C4 (mg/dL) | 19 | 13–35 |
| Anti-ds-DNA antibody (IU/mL) | < 10 | < 10 |
| Anti-β2-GPI antibody (IU/mL) | < 1.2 | < 1.2 |
| Anti- cardiolipin antibody (IU/mL) | < 8 | < 8 |
| Lupus anticoagulant (IU/mL) | 2.61 | < 1.29 |
| ADAMTS13 activity (%) | 100 | > 10 |
BUN blood urea nitrogen, Cr creatinine, eGFR estimated glemerular filtration rate, UA uric acid, ALP alkaline phosphatase, ALT alanine aminotransferase, AST aspartate aminotransferase, LDH lactate dehydrogenase, PT prothrombin time, APTT activated partial thromboplastin time, CRP C-reactive protein, CH50 total hemolytic complement, GPI glycoprotein I, ADAMTS13 disintegrin-like and metalloproteinase with thrombospondin type 1 motifs 13